Rare Bone Disease TeleECHO Clinic Series

The goal of this educational program, a partnership with Project ECHO™ (Extension for Community Healthcare Outcomes), the Rare Bone Disease Alliance (RBDA), and the Osteogenesis Imperfecta Foundation (OIF) is to build capacity to safely and effectively diagnose and treat rare bone diseases and disorders. Each monthly session includes a main presentation, participant-led case presentations, and group discussions. Sessions are held on Zoom on the 1st Thursday of each month, and free CME is available for attendees.

Recordings of all the main presentations and more information are available to view on the OIF website. The links to upcoming live sessions can also be found below.

The Brittle Bone Disorders Consortium (BBD) is part of the Rare Diseases Clinical Research Network (RDCRN), which is funded by the National Institutes of Health (NIH) and led by the National Center for Advancing Translational Sciences (NCATS) through its Office of Rare Diseases Research (ORDR). BBD is funded under grant number U54AR068069 as a collaboration between NCATS, the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and the National Institute of Dental and Craniofacial Research (NIDCR).  

2021-2022 Agenda

August 5, 2021; 3:00pm ET, Differential Diagnosis of Overgrowth Conditions
Matthew Warman, MD, Director, Orthopedic Research Laboratories Professor of Orthopedic Surgery Boston Children’s Hospital

September 2, 2021; 3:00pm ET, Skeletal Presentations of Lyosomal Storage Diseases
Patricia Dickson, MD Centennial Professor of Pediatrics and Genetics; Chief, Division of Genetics and Genomic Medicine, Washington University School of Medicine in St. Louis

October 14, 2021; 3:00pm ET, Paget’s Disease of Bone
Frederick R. Singer, MD Director, Endocrine-Bone Disease Program St. Johns Cancer Institute Clinical Professor Medicine, UCLA

November 4, 2021; 3:00pm ET, The Dysmorphology Exam for Skeletal Dysplasias
Danita Velasco, MD, FAAP, FACMG Assistant Professor, Pediatrics and Genetics, Munroe-Meyer Institute for Genetics & Rehabilitation, University of Nebraska Medical Center

December 2, 2021; 3:00pm ET, Pulmonary Challenges in OI
Cathleen Raggio, MD Co-Director of the Kathryn O. and Alan C. Greenberg Center for Skeletal Dysplasias at Hospital for Special Surgery; Hospital for Special Surgery, New York, NY, Orthopedic Surgeon

January 6, 2022; 3:00pm ET, Genetic Testing – Emerging Diagnostic Technologies
Emily G. Farrow, PhD, CGC Associate Professor of Pediatrics; UMKC School of Medicine; Director of Laboratory Operations Genomic Medicine Center, Children’s Mercy Hospital

February 3, 2022; 3:00pm ET, Hypoparathyroidism
Rachel Gafni, MD Senior Research Physician; Head, Mineral Homeostasis Unit, Skeletal Disorders and Mineral Homeostasis Section National Institutes of Dental and Craniofacial Research, NIH

March 3, 2022; 3:00pm ET, Dense Bone Diseases: Too Much Of A Bad Or Good Thing
Michael Whyte, MD Medical Director at the Center for Metabolic Bone Disease and Molecular Research at Shriners Hospitals for Children — St. Louis; Professor of Medicine, Pediatrics, and Genetics at Washington University School of Medicine

April 7, 2022; 3:00pm ET, FOP and Anesthesia
Zvi Grunwald, MD, FASA Executive Director, The Jefferson Israel Center, The James D. Wentzler Professor and Emeritus Chair of Anesthesiology; Professor of Pediatrics, Sidney Kimmel Medical College at Thomas Jefferson University

May 5, 2022; 3:00pm ET, Differential Diagnosis of non-XLH FGF 23 Disorders
Sherri-Ann M. Burnett-Bowie, MD, MPH Assistant Professor of Medicine, Harvard Medical School

June 2, 2022; 3:00pm ET, Achondroplasia
Michael B. Bober, MD, PhD Director, Skeletal Dysplasia Program A.I. DuPont Hospital for Children; Professor of Pediatrics Stanley Kimmel Medical College, Thomas Jefferson University

July 7, 2022; 3:00pm ET, MCTO
Nina Ma, MD Ed and Jeannette Kerr Family Endowed Chair in Endocrinology; Director, Bone and Mineral Metabolism Program, Children’s Hospital Colorado; Associate Professor of Pediatrics, University of Colorado School of Medicine

 

2020-2021 Agenda 

August 6, 2020; 3:00pm ET, Melorheostosis: The Genes Behind the Dripping Candle Wax
Timothy Bhattachyrra, MD  Orthopaedic Surgery, NIAMS/NIH

September 3, 2020; 3:00pm ET, Evaluation of Patients with Hyperphosphatemia
Michael Collins, MD Senior Investigator, Skeletal Disorders and Mineral Homeostasis Section, National Institute of Dental and Craniofacial Research/NIH

October 1, 2020; 3:00pm ET, Mechanisms of Bone Loss in Complex Lymphatic Anomalies
Michael Kelly, MD, PhD Professor of Pediatrics, Northeast Ohio Medical University

November 5, 2020; 3:00pm ET, Dental Concerns in Patients with Rare Bone Disorders
Tim Wright, DDS, MS Bawden Distinguished Professor, Division of Pediatrics and Public Health, Adams School of Dentistry, University of North Carolina

December 3, 2020; 3:00pm ET, Generalized Arterial Calcification of Infancy (GACI)
Carlos Ferreira, MD ChiefSkeletal Genomics Unit, National Human Genome Research Institute, NIH

January 7, 2021; 3:00pm ET, Skeletal Surveys – A Systematic Approach
Dorothy Bulas, MD Chief, Department of Radiology, Children’s National Hospital; Professor of Pediatrics and Radiology, George Washington University School of Medicine

February 4, 2021; 3:00pm ET, Jansen’s Disease
Harald Jueppner, MD Chief, Pediatric Nephrology, Massachusetts General Hospital; Professor of Pediatrics, Harvard Medical School

March 4, 2021; 3:00pm ET, Bone Pain in Children
Alison Boyce, MD Associate Research Physician, National Institute of Dental and Craniofacial Research, NIH

April 1, 2021; 3:00pm ET, Multiple Hereditary Exostoses
David S. Feldman, MD Co-Director, Multiple Hereditary Exostoses Center, St. Mary’s Medical Center, West Palm Beach, FL

May 6, 2021; 3:00pm ET, DXA Evaluation in the Child
Catherine Gordon, MD Adolescent Chief, Boston Children’s Hospital; Robert P. Masland, Jr. Chair of Adolescent Medicine, Professor of Pediatrics, Harvard Medical School

June 3, 2021; 3:00pm ET, Adult Hypophosphatasia
Kathryn Dahir, MD Professor of Medicine, Vanderbilt University Medical Center 

July 1, 2021; 3:00pm ET, Evaluation of the Child with Multiple Fractures
Eric. T. Rush, MD, FAAP, FACMG Clinical Geneticist, Children’s Mercy Kansas City; Associate Professor of Pediatrics, University of Missouri-Kansas City School of Medicine; Clinical Associate Professor of Medicine, University of Kansas School of Medicine

2019-2020 Agenda 

August 1, 2019; Genetic Testing in the Diagnosis of Rare Bone Disease
Eric Rush MD, FAAP, FACMG, Associate Professor of Medicine at the University of Kansas Medical Center and Associate Professor of Pediatrics at University of Missouri – Kansas City

September 5, 2019; OI Dominant vs Recessive: Impact on Treatment
Reid Sutton MD, Medical Director of Biochemical Genetics Laboratory, Director of Medical Genetics Residency Program and ABMGG Diagnostic Laboratory Training Program at Baylor College of Medicine, and Director of Inborn Errors of Metabolism Service at Texas Children’s Hospital

October 3, 2019; Hypocalcemia
Dolores Shoback MD, Professor of Medicine and Director of the UCSF Training Program in Diabetes, Endocrinology, and Metabolism at the University of California San Francisco (UCSF) Health

November 7, 2019; Fibrous Dysplasia – McCune Albright 
Michael Collins MD, Senior Clinical Investigator, Skeletal Disorders, and Mineral Homeostasis Section at NIH NIDCR

December 5, 2019; Non-Accidental Trauma
Peter Byers MD, Professor of Medicine, Pathology, and Medical Genetics at University of Washington Medicine

January 2, 2020; XLH Disorders
Thomas Carpenter MD, Professor of Pediatric Endocrinology, Orthopaedics, and Rehabilitation, Clinical Professor of Nursing, Director of the Yale Center for X-Linked Hypophosphatemia (XLH), and Medical Director of the Hospital Research Unit at Yale School of Medicine

February 6, 2020; Diagnostic Approach to the Child with a Skeletal Dysplasia
Julie Hoover-Fong MD, PhD, Director of the Greenberg Center for Skeletal Dysplasias and Professor of Pediatrics at Johns Hopkins Medicine

March 5, 2020; Hypophosphatasia
Michael Whyte MD, Medical Director at the Center for Metabolic Bone Disease and Molecular Research at Shriners Hospitals for Children — St. Louis and Professor of Medicine, Pediatrics, and Genetics at Washington University School of Medicine

April 2, 2020; Evaluation of the Child with Rickets 
Erik Imel MD, Associate Professor of Medicine and Pediatrics at Indiana University School of Medicine

May 7, 2020; Osteopetrosis
Michael Econs MD, Professor of Medical & Molecular Genetics and Division Chief of Endocrinology and Metabolism at Indiana University School of Medicine

June 4, 2020; Fibrodysplasia Ossificans Progressiva 
Edward Hsiao MD, PhD, Associate Professor of Medicine at University of California San Francisco (UCSF) Health 

July 2, 2020; Management of Pregnancy & Delivery in the Patient with a Skeletal Disorder 
Deborah Krakow MD, Chair of the Department of Obstetrics and Gynecology, Professor of Orthopaedic Surgery, and Professor of Human Genetics at University of California Los Angeles (UCLA) Health

Learning Objectives

Improve the diagnosis, evaluation, and treatment of individuals with rare bone diseases.

Brittle Bone Disorders Consortium (BBD)
Level
Skilled
Time Required
1-18 hours
Fee
No
Availability
On demand
Delivery Method
Online
Date Created

Submitted by Michael Stewart on Tue, 12/01/2020 - 12:13 . Last modified on 11/03/2021